June 22 — Vice Minister of Commerce and deputy chief trade negotiator Ling Ji met with a delegation from the Asia‑Pacific Medical Technology Association and member firms to discuss the operating environment and concerns of foreign medtech companies in China. Ling said that during the 15th Five‑Year Plan period China will accelerate development of biopharma and other emerging pillar industries, advance the Healthy China agenda, and welcomes multinational pharmaceutical and medtech companies to de

2026-06-22

June 22 — Vice Minister of Commerce and deputy chief trade negotiator Ling Ji met with a delegation from the Asia‑Pacific Medical Technology Association and member firms to discuss the operating environment and concerns of foreign medtech companies in China. Ling said that during the 15th Five‑Year Plan period China will accelerate development of biopharma and other emerging pillar industries, advance the Healthy China agenda, and welcomes multinational pharmaceutical and medtech companies to deepen cooperation, expand in‑China R&D, and increase localization of production and supply chains to help safeguard global pharmaceutical supply‑chain stability. The association and member firms said they see significant market potential in China and plan to increase investment, deepen local partnerships and intensify regional technology exchanges.

其他消息
2026-06-22

美國至6月22日3個月國債競拍-得標利率 3.695%,前值3.64%。

2026-06-22

The second-review draft amendment to China’s Trademark Law will be submitted to the 23rd session of the 14th NPC Standing Committee, the Legislative Affairs Commission said. Spokesperson Huang Haihua said on the 22nd the revision targets deceptive trademarks with three measures: tighten registration review; broaden complaint and reporting channels; and increase legal liability. Where a registered trademark is used in a way that misleads the public, trademark enforcement authorities may order rec